Skip to main content
Erschienen in: Clinical and Translational Oncology 3/2017

07.09.2016 | Research Article

Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients

verfasst von: Mª A. Vaz Salgado, M. Soto, Mª E. Reguero, G. Muñoz, A. Cabañero, I. Gallego, S. Resano, F. Longo, A. Madariaga, A. Gomez, A. Carrato

Erschienen in: Clinical and Translational Oncology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Solitary fibrous tumors (SFTs) are a rare type of soft tissue sarcoma of unpredictable clinical behavior. Some clinicopathologic characteristics have also been related to patient outcome.

Methods

This study is a retrospective review of 30 patients. We analyzed the clinical course and pathological factors to predict recurrence.

Results

The mean age was 55.9 years. Forty-five percent were located in the thoracic region. The mean tumor size was 10 cm (max24). Thirty-three percent had a relapse and 20 % have died. Median time to relapse was 7.18 (1–13) years. Median overall survival (OS) was 15.5 years (0–32). On histopathologic analysis, 6 % percent had >4 mitoses, 23 % had necroses, and 36 % had atypia/pleomorphism. Forty-three percent had tumor size >10 cm. Forty-six percent had at least one characteristic of malignancy. None of this data could predict clinical behavior by itself.

Conclusions

SFT can be an aggressive disease and relapses can occur several years from diagnosis. We did not find any clinicopathologic factors that could predict the tumor behavior accurately. Nevertheless, it should be consider that we included different tumor locations and the sample size is small.
Literatur
1.
Zurück zum Zitat Gengler C, Guillou L. Solitary fibrous tumor and hemangiopericytoma: evolution of a concept. Histopathology. 2006;28:67–74. Gengler C, Guillou L. Solitary fibrous tumor and hemangiopericytoma: evolution of a concept. Histopathology. 2006;28:67–74.
2.
Zurück zum Zitat Hanau CA, Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol. 1995;26:440–9.CrossRefPubMed Hanau CA, Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol. 1995;26:440–9.CrossRefPubMed
3.
Zurück zum Zitat Gold JS, Antonescu CR, Hajdu C, Ferrone CR, Hussain M, Lewis JJ, et al. Clinocopathologic correlates of solitry fibrous tumor. Cancer. 2002;94(4):1057–8.CrossRefPubMed Gold JS, Antonescu CR, Hajdu C, Ferrone CR, Hussain M, Lewis JJ, et al. Clinocopathologic correlates of solitry fibrous tumor. Cancer. 2002;94(4):1057–8.CrossRefPubMed
4.
Zurück zum Zitat Pitluk HC, Conn J Jr. Hemangiopericytoma. Literature review and clinical presentations. Am J Surg. 1979;137:413–6.CrossRefPubMed Pitluk HC, Conn J Jr. Hemangiopericytoma. Literature review and clinical presentations. Am J Surg. 1979;137:413–6.CrossRefPubMed
6.
Zurück zum Zitat England MD, Hochholzer L, McCarthy MJ. Localized benig and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13:640–58.CrossRefPubMed England MD, Hochholzer L, McCarthy MJ. Localized benig and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13:640–58.CrossRefPubMed
7.
Zurück zum Zitat Lahon B, Mercier O, Fadel E, Ghigna MR, Petkova B, Mussot S, et al. Solitary fibrous tumor of the pleura: outcomes of 157 complete resections in a single center. Ann Thorac Surg. 2012;94(2):394–400.CrossRefPubMed Lahon B, Mercier O, Fadel E, Ghigna MR, Petkova B, Mussot S, et al. Solitary fibrous tumor of the pleura: outcomes of 157 complete resections in a single center. Ann Thorac Surg. 2012;94(2):394–400.CrossRefPubMed
8.
Zurück zum Zitat Fletcher CDM, Bridge JA, Hogendoorn P, Martens F. World Health Organization (WHO) classification of tumours of soft tissue and bone. Pathology and genetics. Lyon: IARC Press; 2013. Fletcher CDM, Bridge JA, Hogendoorn P, Martens F. World Health Organization (WHO) classification of tumours of soft tissue and bone. Pathology and genetics. Lyon: IARC Press; 2013.
9.
Zurück zum Zitat Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011;117:4939–47.CrossRefPubMedPubMedCentral Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011;117:4939–47.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Guillerme F, Truntzer P, Prim N, Chenard MP, Voirin J, Noël G. Solitary fibrous tumors: case report of a late relapse. Cancer Radiother. 2011;15:330–3.CrossRefPubMed Guillerme F, Truntzer P, Prim N, Chenard MP, Voirin J, Noël G. Solitary fibrous tumors: case report of a late relapse. Cancer Radiother. 2011;15:330–3.CrossRefPubMed
11.
Zurück zum Zitat Park CK, Lee DH, Park JY, Park SH, Kwon KY. Multiple recurrent malignant solitary fibrous tumors: long-term follow-up of 24 years. Ann Thorac Surg. 2011;91:1285–8.CrossRefPubMed Park CK, Lee DH, Park JY, Park SH, Kwon KY. Multiple recurrent malignant solitary fibrous tumors: long-term follow-up of 24 years. Ann Thorac Surg. 2011;91:1285–8.CrossRefPubMed
12.
Zurück zum Zitat Mohamed H, Mandal AK. Natural history of multifocal solitary fibrous tumors of the pleura: a 25-year follow-up report. J Natl Med Assoc. 2004;96:659–62.PubMedPubMedCentral Mohamed H, Mandal AK. Natural history of multifocal solitary fibrous tumors of the pleura: a 25-year follow-up report. J Natl Med Assoc. 2004;96:659–62.PubMedPubMedCentral
13.
Zurück zum Zitat Oliaro A, Filosso PL, Casadio C, Ruffini E, Cianci R, Porrello C, et al. Il mesotelioma fibroso benigno della pleura. Minerva Chir. 1994;49:1311–6.PubMed Oliaro A, Filosso PL, Casadio C, Ruffini E, Cianci R, Porrello C, et al. Il mesotelioma fibroso benigno della pleura. Minerva Chir. 1994;49:1311–6.PubMed
14.
Zurück zum Zitat Masson EA, MacFarlane IA, Graham D, Foy P. Spontaneous hypoglicemia due to a pleural fibroma: role of insulin like growth factors. Thorax. 1991;46:930–1.CrossRefPubMedPubMedCentral Masson EA, MacFarlane IA, Graham D, Foy P. Spontaneous hypoglicemia due to a pleural fibroma: role of insulin like growth factors. Thorax. 1991;46:930–1.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat de Perrot M, Fischer S, Bründler MA, Sekine Y, Keshavjee S. Solitary fibrous tumors of the pleura. Ann Thorac Surg. 2002;74:285–93.CrossRefPubMed de Perrot M, Fischer S, Bründler MA, Sekine Y, Keshavjee S. Solitary fibrous tumors of the pleura. Ann Thorac Surg. 2002;74:285–93.CrossRefPubMed
16.
Zurück zum Zitat Mosquera JM, Fletcher CD. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component—is this dedifferentiated SFT? Am J Surg Pathol. 2009;33:1314–21.CrossRefPubMed Mosquera JM, Fletcher CD. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component—is this dedifferentiated SFT? Am J Surg Pathol. 2009;33:1314–21.CrossRefPubMed
17.
Zurück zum Zitat Tapias LF, Mino-Kenudson M, Lee H, Wright C, Gaissert HA, Wain JC, et al. Risk factor analysis for the recurrence of resected solitary fibrous tumors of the pleura: a 33-year experience and proposal for a scoring system. Eur J Cardiothorac Surg. 2013;44(1):111–7. doi:10.1093/ejcts/ezs629.CrossRefPubMed Tapias LF, Mino-Kenudson M, Lee H, Wright C, Gaissert HA, Wain JC, et al. Risk factor analysis for the recurrence of resected solitary fibrous tumors of the pleura: a 33-year experience and proposal for a scoring system. Eur J Cardiothorac Surg. 2013;44(1):111–7. doi:10.​1093/​ejcts/​ezs629.CrossRefPubMed
18.
Zurück zum Zitat Baldi GG, Stacchiotti S, Mauro V, Dei Tos AP, Gronchi A, Pastorino U, et al. Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients. Clin Sarcoma Res. 2013;3:4–11.CrossRefPubMedPubMedCentral Baldi GG, Stacchiotti S, Mauro V, Dei Tos AP, Gronchi A, Pastorino U, et al. Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients. Clin Sarcoma Res. 2013;3:4–11.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Magdeleinat P, Alifano M, Petino A, Le Rochais JP, Dulmet E, Galateau F, et al. Solitary fibrous tumors of the pleura: clinical characteristics, surgical treatment and outcome. Eur J Cardio Thorac Surg. 2002;21:1087–93.CrossRef Magdeleinat P, Alifano M, Petino A, Le Rochais JP, Dulmet E, Galateau F, et al. Solitary fibrous tumors of the pleura: clinical characteristics, surgical treatment and outcome. Eur J Cardio Thorac Surg. 2002;21:1087–93.CrossRef
20.
Zurück zum Zitat Rena O, Filosso PL, Papalia E, Molinatti M, Di Marzio P, Maggi G, et al. Solitary fibrous tumors of the pleura: surgical treatment. Eur J Cardio Thorac Surg. 2001;19:185–9.CrossRef Rena O, Filosso PL, Papalia E, Molinatti M, Di Marzio P, Maggi G, et al. Solitary fibrous tumors of the pleura: surgical treatment. Eur J Cardio Thorac Surg. 2001;19:185–9.CrossRef
21.
Zurück zum Zitat Cardillo G, Facciolo F, Cavazzana AO, Capece G, Gasparri R, Martelli M. Localized (solitary) fibrous tumors of the pleura: an analysis of 55 patients. Ann Thorac Surg. 2000;70:1808–12.CrossRefPubMed Cardillo G, Facciolo F, Cavazzana AO, Capece G, Gasparri R, Martelli M. Localized (solitary) fibrous tumors of the pleura: an analysis of 55 patients. Ann Thorac Surg. 2000;70:1808–12.CrossRefPubMed
22.
Zurück zum Zitat Brozzetti S, DÁndrea N, Limit MR, Pisanelli MC, De Angelis R, Carvallo A. Clinical behavior of solitary fibrous tumors of the pleura: an inmunohistochemical study. Anticancer Res. 2000;20:4701–6.PubMed Brozzetti S, DÁndrea N, Limit MR, Pisanelli MC, De Angelis R, Carvallo A. Clinical behavior of solitary fibrous tumors of the pleura: an inmunohistochemical study. Anticancer Res. 2000;20:4701–6.PubMed
23.
Zurück zum Zitat Brunnemann RB, Ro JY, Ordonez NG, Mooney J, El-Naggar AK, Ayala AG. Extrapleural solitary fibrous tumor: a clinic-pathologic study of 24 cases. Mod pathol. 1999;12:1034–42.PubMed Brunnemann RB, Ro JY, Ordonez NG, Mooney J, El-Naggar AK, Ayala AG. Extrapleural solitary fibrous tumor: a clinic-pathologic study of 24 cases. Mod pathol. 1999;12:1034–42.PubMed
24.
Zurück zum Zitat Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012;25(9):1298–306.CrossRefPubMed Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012;25(9):1298–306.CrossRefPubMed
25.
Zurück zum Zitat Lococo F, Cusumano G, Margaritora S, Cardillo G, Filosso P, Cesario A. Tapias score for predicting recurrences in resected solitary fibrous tumor of the pleura: controversial points and future perspectives emerging from an external validation. Chest. 2015;147(3):e115–6.CrossRefPubMed Lococo F, Cusumano G, Margaritora S, Cardillo G, Filosso P, Cesario A. Tapias score for predicting recurrences in resected solitary fibrous tumor of the pleura: controversial points and future perspectives emerging from an external validation. Chest. 2015;147(3):e115–6.CrossRefPubMed
26.
Zurück zum Zitat Schirosi L, Lantuejoul S, Cavazza A, Murer B, Yves Brichon P, Migaldi M, et al. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR. Am J Surg Pathol. 2008;32(11):1627–42.CrossRefPubMed Schirosi L, Lantuejoul S, Cavazza A, Murer B, Yves Brichon P, Migaldi M, et al. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR. Am J Surg Pathol. 2008;32(11):1627–42.CrossRefPubMed
27.
Zurück zum Zitat Saifuddin A, Da Costa P, Chalmers AG, Carey BM, Robertson RJ. Primary malignant localized fibrous tumors of the pleura: clinical, radiological, and pathological features. Clin Radiol. 1992;45:13–7.CrossRefPubMed Saifuddin A, Da Costa P, Chalmers AG, Carey BM, Robertson RJ. Primary malignant localized fibrous tumors of the pleura: clinical, radiological, and pathological features. Clin Radiol. 1992;45:13–7.CrossRefPubMed
28.
Zurück zum Zitat Park MS, Patel S, Ravi V, Conley AP, Trent JC, Lazar AJF, et al. The role of chemotherapy in advanced hemangipeicytoma/solitary fibrous tumor. J Clin Oncol. 2011; 29, abstr 10097. Park MS, Patel S, Ravi V, Conley AP, Trent JC, Lazar AJF, et al. The role of chemotherapy in advanced hemangipeicytoma/solitary fibrous tumor. J Clin Oncol. 2011; 29, abstr 10097.
29.
Zurück zum Zitat Khalifa J, Ouali M, Chaltiel L, Le Guellec S, Le Cesne A, Blay JY, Cousin P, Chaigneau L, Bompas E, Piperno-Neumann S, Bui-Nguyen B, Rios M, Delord JP, Penel N, Chevreau C. Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group. BMC Cancer. 2015;15(15):700.CrossRefPubMedPubMedCentral Khalifa J, Ouali M, Chaltiel L, Le Guellec S, Le Cesne A, Blay JY, Cousin P, Chaigneau L, Bompas E, Piperno-Neumann S, Bui-Nguyen B, Rios M, Delord JP, Penel N, Chevreau C. Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group. BMC Cancer. 2015;15(15):700.CrossRefPubMedPubMedCentral
Metadaten
Titel
Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients
verfasst von
Mª A. Vaz Salgado
M. Soto
Mª E. Reguero
G. Muñoz
A. Cabañero
I. Gallego
S. Resano
F. Longo
A. Madariaga
A. Gomez
A. Carrato
Publikationsdatum
07.09.2016
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 3/2017
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-016-1536-7

Weitere Artikel der Ausgabe 3/2017

Clinical and Translational Oncology 3/2017 Zur Ausgabe

Acknowledgement to Reviewers

Thanks to reviewers

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.